NGNE — Neurogene Inc. stock price, charts and financials

QT83Neurogene Inc.

Neurogene Inc. (NASDAQ: NGNE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
34.41
+1.54+4.69%
OverviewShort InterestFilings
NGNEQT83Neurogene Inc.·NASDAQ
34.41+4.69%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 2026424B5Prospectus
Jun 30, 2026424B5Prospectus
Jun 29, 20268-KCurrent report
Jun 16, 20263/AInitial statement of beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 16, 20264/AStatement of changes in beneficial ownership (amended)
Jun 08, 20268-KCurrent report
Jun 04, 20268-KCurrent report
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 08, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
Apr 20, 20263Initial statement of beneficial ownership
Apr 20, 20268-KCurrent report
Apr 16, 2026ARSAnnual report to shareholders
Apr 16, 2026DEF 14ADefinitive proxy statement
Apr 16, 2026DEFA14AAdditional proxy soliciting materials
Mar 30, 20264Statement of changes in beneficial ownership
Mar 30, 20264Statement of changes in beneficial ownership
Mar 30, 20264Statement of changes in beneficial ownership
Mar 24, 2026S-8Registration of employee benefit securities
#1 / 25 of 140
Page
▼
/ 6